source
- Endpoints Weekly celebrates Neal Awards while previewing Sanofi, Lilly and RevMed updatesEndpoints Weekly released its latest edition on April 25, 2026, noting a celebratory tone after the publication earned three Neal Awards for B2B journalism excellence. The issue highlights several…
- Eli Lilly to acquire cancer cell therapy startup Kelonia Therapeutics for $3.2 billionEli Lilly announced it will buy privately held Kelonia Therapeutics, a biotech focused on cell therapies for cancer and autoimmune diseases, in a deal valued at $3.2 billion. Kelonia has operated…